The purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease.
Aortic Valve Disease
The purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease.
Avalus Ultra Post-Approval Study (PAS)
-
Northwestern Memorial Hospital, Chicago, Illinois, United States, 60611
University of Michigan Health System - University Hospital, Ann Arbor, Michigan, United States, 48109
Heart Hospital of Austin, Austin, Texas, United States, 78756
Houston Methodist Hospital, Houston, Texas, United States, 77030
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Medtronic Cardiac Surgery,
Juan Crestanello, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic
Bo Yang, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Michigan
2026-11